Loading
Conversational AI system vs Usual Care / Major Depressive Disorder (MDD) · Interventional Study
ClinicalTrials.gov · September 9, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a registered but not yet completed interventional trial examining whether a conversational AI intake system affects patient perceptions of empathy compared to usual clinical care in individuals with major depressive disorder. No results are posted; the study remains in recruitment and will follow participants for four months after AI exposure.
Interventional, Single Group, Open label, Health Services Research purpose. Major Depressive Disorder (MDD); age from 18 Years; to 85 Years. Intervention: Conversational AI system vs Usual Care. Compared with: Usual clinical care. n = 130. 1 site: United States.
This is a registered but not yet completed interventional trial examining whether a conversational AI intake system affects patient perceptions of empathy compared to usual clinical care in individuals with major depressive disorder. No results are posted; the study remains in recruitment and will follow participants for four months after AI exposure.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is a study registration with no posted results; it describes a planned interventional trial in major depressive disorder using a surrogate endpoint (perceptions of empathy) in a small, single-centre cohort with within-subject design.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07105397). This is a study registration, not published results. Lead sponsor: George Mason University. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 130 participants (ESTIMATED). Conditions: Major Depressive Disorder (MDD). Interventions: OTHER: Conversational AI system vs Usual Care. Primary outcome measures: Perceptions of empathy , From enrollment up to 4 months after participation. Brief summary: The goal of this clinical trial is to evaluate how a conversational method of collecting medical history affects patients' perceptions and experiences compared to clinical care as usual. This conversational AI intake system collects medical history information, can be completed by participants at home, and do not disrupt routine clinical care. The primary questions this study aims to answer are: 1\) Does conversational intake affect patients' perceptions of empathy during their clinical interactions? This will be a prospective study that follows a cohort of participants for four (4) months after engaging with the AI intake system. Because each participant serves as his/her own control, both comparators will be administered within-subject, and the order of exposure (AI intake vs. usual care) will be randomized to minimize sequence effects. After completing the AI intake method, participants will rate their experience, particularly in terms of empathy and compare it to their usual interactions with their own clinicians.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.